84449-81-0 + 63675-74-1 = 82640-04-8 反应条件:1.1 Reagents: Aluminum Chloride; 30 Min,Rt; Rt -> 30 °C; 2 H,25 - 35 °C1.2 Reagents: 1-Decanethiol; 2 H,25 - 35 °C1.3 Reagents: Hydrogen,Hydrochloric Acid Solvents: Methanol; 1 H,25 - 35 °C 标题:Industrially Viable Demethylation Reaction In Synthesis Of Raloxifene Hydrochloride 作者:Chavakula,R.; Et Al 参考文献:Organic Chemistry: An Indian Journal 日期:2018 卷标:14(3)]
84449-90-1 = 82640-04-8 反应条件:1.1 Reagents: Hydrochloric Acid Solvents: Tetrahydrofuran 标题:Synthesis Of Raloxifene Hydrochloride 作者:Gong,Ping; Et Al 参考文献:Shenyang Yaoke Daxue Xuebao 日期:2003 卷标:20(2) 页码:111-113]
84449-80-9 + 63675-74-1 = 82640-04-8 反应条件:1.1 Reagents: Thionyl Chloride Solvents: Dichloromethane; 15 - 30 Min,25 - 35 °C; 2 H,40 - 45 °C1.2 Reagents: Aluminum Chloride Solvents: Dichloromethane; 30 Min,0 - 10 °C; 10 °C -> 30 °C; 2 H,25 - 35 °C1.3 Reagents: 1-Decanethiol; 2 H,25 - 35 °C1.4 Reagents: Hydrochloric Acid Solvents: Methanol,Water; 1 H,25 - 35 °C 标题:A Green Process For Demethylation Reaction In Synthesis Of Raloxifene Hydrochloride 作者:Chavakula,Ramadas; Et Al 参考文献:Journal Of The Indian Chemical Society 日期:2019 卷标:96(3) 页码:391-393]
84449-80-9 + 63675-74-1 = 82640-04-8 反应条件:1.1 Reagents: Chlorobenzene,Thionyl Chloride Solvents: Dimethylformamide,Dichloromethane,Pyridine; 25 - 35 °C; 2 H,40 - 45 °C1.2 Reagents: Aluminum Chloride; 30 Min,Rt; 2 H,25 - 35 °C1.3 Reagents: 1-Decanethiol; 2 H,25 - 35 °C1.4 Reagents: Hydrogen,Hydrochloric Acid Solvents: Methanol; 1 H,25 - 35 °C 标题:Industrially Viable Demethylation Reaction In Synthesis Of Raloxifene Hydrochloride 作者:Chavakula,R.; Et Al 参考文献:Organic Chemistry: An Indian Journal 日期:2018 卷标:14(3)]
84449-81-0 + 63675-74-1 = 82640-04-8 反应条件:1.1 Reagents: Aluminum Chloride Solvents: Dichloromethane; 30 Min,0 - 10 °C; 10 °C -> 30 °C; 2 H,25 - 35 °C1.2 Reagents: 1-Decanethiol; 2 H,25 - 35 °C1.3 Reagents: Hydrochloric Acid Solvents: Methanol,Water; 1 H,25 - 35 °C 标题:A Green Process For Demethylation Reaction In Synthesis Of Raloxifene Hydrochloride 作者:Chavakula,Ramadas; Et Al 参考文献:Journal Of The Indian Chemical Society 日期:2019 卷标:96(3) 页码:391-393]
1627905-24-1 = 82640-04-8 反应条件:1.1 Solvents: Dimethylformamide; Rt; 4 H,80 - 85 °C2.1 Reagents: Ethanethiol,Aluminum Chloride Solvents: 1-Ethyl-3-(3′-Dimethylaminopropyl)Carbodiimide Hydrochloride; 15 Min,0 - 5 °C; 10 Min,0 - 5 °C2.2 Solvents: 1-Ethyl-3-(3′-Dimethylaminopropyl)Carbodiimide Hydrochloride; 20 Min,0 - 5 °C; 3 H,Rt; Rt -> 0 °C2.3 Solvents: Tetrahydrofuran; 30 Min,0 - 5 °C2.4 Reagents: Water; 15 Min,Cooled2.5 Reagents: Hydrochloric Acid; 10 H,Rt 标题:Expeditious Synthesis Of 3-Aryl Benzothiophene A Raloxifene Intermediate 作者:Umareddy,Pailla; Et Al 参考文献:Journal Of Chemical And Pharmaceutical Research 日期:2017 卷标:9(10) 页码:106-110]
专利号:US-6372945-B1 优先权日:1995-06-07 标 题 :Process for the synthesis of vinyl sulfoxides 发明人:AIKINS JAMES A; MILLER RANDAL SCOT; ZHANG TONY Y 权利人:LILLY CO ELI 摘要:The present invention is directed to a new process for the synthesis of vinyl sulfoxides, in particular diarylvinyl sulfoxides
专利号:US-5606076-A 优先权日:1995-06-07 标 题 :Process for the synthesis of benzo[b]thiophenes 发明人:AIKINS JAMES A; ZHANG TONY Y 权利人:LILLY CO ELI 摘要:The present invention is directed to a process for the synthesis of 2-arylbenzo[b]thiophenes.
专利号:US-5569772-A 优先权日:1995-06-07 标 题:Process for the synthesis of benzo[b]thiophenes 发明人:HOARD DAVID W; LUKE WAYNE D 权利人:LILLY CO ELI 摘要:The present invention is directed to a new process for the synthesis of 2-aryl benzo[b]thiophenes, and to novel intermediates therefor.
专利号:US-5606075-A 优先权日:1995-06-07 标 题:Process for the synthesis of benzo[b]thiophenes 发明人:HOARD DAVID W; LUKE WAYNE D 权利人:LILLY CO ELI 摘要:The present invention is directed to new processes for the synthesis of 2-aryl benzo[b]thiophenes.
专利号:WO-2017100796-A1 优先权日:2015-12-11 标 题 :Modulation of globoseries glycosphingolipid synthesis and cancer biomarkers 发明人:WONG CHI-HUEY; HSU TSUI-LING; WU CHUNG-YI; CHEUNG SARAH K C; CHUANG PO-KAI 权利人:SINACA ACAD; WONG CHI-HUEY; HSU TSUI-LING 摘要:The present disclosure relates to methods and compositions which can modulate the globoseries glycosphingolipid synthesis. Particularly, the present disclosure is directed to glycoenzyme inhibitor compound and compositions and methods of use thereof that can modulate the synthesis of globoseries glycosphingolipid SSEA-3/SSEA-4/GloboH in the biosynthetic pathway; particularly, the glycoenzyme inhibitors target the alpha-4GalT; beta- 4GalNAcT-I; or beta-3GalT-V enzymes in the globoseries synthetic pathway. Additionally, the present disclosure is also directed to vaccines, antibodies, and/or immunogenic conjugate compositions targeting the SSEA-3/SSEA-4/GLOBO H associated epitopes (natural and modified) which elicit antibodies and/or binding fragment production useful for modulating the globoseries glycosphingolipid synthesis. Moreover, the present disclosure is also directed to the method of using the compositions described herein for the treatment or detection of hyperproliferative diseases and/or conditions. Furthermore, the instant disclosure also relates to cancer stem cell biomarkers for disgnostic and therapeutic uses.
专利号:US-2017283878-A1 优先权日:2015-12-11 标题:Modulation of globoseries glycosphingolipid synthesis and cancer biomarkers 发明人:WONG CHI-HUEY; WU CHUNG-YI; CHEUNG SARAH K C; CHUANG PO-KAI; HSU TSUI-LING 权利人:ACADEMIA SINICA 摘要:The present disclosure relates to methods and compositions which can modulate the globoseries glycosphingolipid synthesis. Particularly, the present disclosure is directed to glycoenzyme inhibitor compound and compositions and methods of use thereof that can modulate the synthesis of globoseries glycosphingolipid SSEA-3/SSEA-4/GloboH in the biosynthetic pathway; particularly, the glycoenzyme inhibitors target the alpha-4GalT; beta-4GalNAcT-I; or beta-3GalT-V enzymes in the globoseries synthetic pathway. Additionally, the present disclosure is also directed to vaccines, antibodies, and/or immunogenic conjugate compositions targeting the SSEA-3/SSEA-4/GLOBO H associated epitopes (natural and modified) which elicit antibodies and/or binding fragment production useful for modulating the globoseries glycosphingolipid synthesis. Moreover, the present disclosure is also directed to the method of using the compositions described herein for the treatment or detection of hyperproliferative diseases and/or conditions. Furthermore, the instant disclosure also relates to cancer stem cell biomarkers for diagnostic and therapeutic uses.
1: Lee J, Kim J, Jeong C, Baek KH, Ha J. Beyond breast cancer: role of selective estrogen receptor modulators in reducing systemic malignancies: evidence from population-based data. Curr Med Res Opin. 2024 Sep;40(9):1589-1596. doi: 10.1080/03007995.2024.2390649. Epub 2024 Aug 18. 16(6):e62997. doi: 10.7759/cureus.62997. 3: Kandel SE, Tooker BC, Lampe JN. Drug metabolism of ciprofloxacin, ivacaftor, and raloxifene by Pseudomonas aeruginosa cytochrome P450 CYP107S1. J Biol Chem. 2024 Aug;300(8):107594. doi: 10.1016/j.jbc.2024.107594. Epub 2024 Jul 18. 4: Demirbaş AE, Mohsen F, Topan C, Karakaya M, Kütük N, Alkan A. The Combined Therapy of Teriparatide and Raloxifene Improves Osseointegration of Dental Implants in the Osteoporotic Rabbit Model. Int J Oral Maxillofac Implants. 2024 Jun 21;(3):435-445. doi: 10.11607/jomi.10040.
合成参考文献
参考文献:10.1016/j.bbrc.2023.08.050 摘要:Ikeda Y, Davis MI, Sumita K, Zheng Y, Kofuji S, Sasaki M, Hirota Y, Pragani R, Shen M, Boxer MB, Takeuchi K, Senda T, Simeonov A, Sasaki AT. Multimodal action of KRP203 on phosphoinositide kinases in vitro and in cells. Biochemical and Biophysical Research Communications. 2023 Oct;679():116–21. doi: 10.1016/j.bbrc.2023.08.050.